NTLA 241220 17.50C (NTLA241220C17500) Stock Options, News & Quotes - Moomoo

US OptionsDetailed Quotes

NTLA241220C17500

Watchlist

0.05
-0.01-16.67%

15min DelayClose Dec 13 16:00 ET

0.10High0.04Low

Intraday

5D
Daily

News

Why Intellia Therapeutics (NTLA) Is the Worst ARK Stock to Buy According to Short Sellers
Yahoo FinanceDec 11 11:57 ET
Lilly Tops Morgan Stanley's Biopharma Pick List for 2025
Seeking AlphaDec 6 16:21 ET
Express News | Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ReutersDec 3 16:01 ET
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswireDec 3 16:01 ET
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
BenzingaNov 26 22:37 ET
NTLA Up as FDA Grants RMAT Status to Genome-Editing Therapy
Zacks Nov 26 10:05 ET

Comments

Big Wealthy Rat

$Intellia Therapeutics (NTLA.US)$ Such a discounted price!

Big Wealthy Rat

$Intellia Therapeutics (NTLA.US)$ Yep, it's fly time!

1

2

Big Wealthy Rat

$Intellia Therapeutics (NTLA.US)$ This is such a buy right now. Cup and handle almost complete, downtrend reversing, the boomers who hold most of the wealth want to live as long as possible, and NTLA seems to have found a way to stop one age-related disorder (ATTR-amyloidosis). This is so going to the moon next year!

5

YWCYAPWEICHOY 叶伟财

Cathie Wood's ARK buys CRISPR, Intellia stock, sells Moderna

time to buy the stock?

Cathie Wood's ARK buys CRISPR, Intellia stock, sells Moderna

3

4

Not Bad. 📊🪵📊

$Intellia Therapeutics (NTLA.US)$ $Recursion Pharmaceuticals (RXRX.US)$

2 Innovative Cathie Wood Stocks to Buy If You Can Stomach the Risk

1

Read more